Company Auris Medical Holding Ltd. Börse Stuttgart
Equities
2QAA
BMG070252017
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
Marcel Gremaud
DFI | Director of Finance/CFO | 66 | 01/21/01 |
Covadonga Pañeda
COO | Chief Operating Officer | 51 | - |
Samuel Wickline
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/21/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alain Munoz
BRD | Director/Board Member | 75 | 01/18/01 |
Mats Blom
BRD | Director/Board Member | 59 | 01/17/01 |
Thomas Meyer
CEO | Chief Executive Officer | 56 | 01/03/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,240,245 | 2,220,245 ( 99.11 %) | 0 | 99.11 % |
Company contact information
Altamira Therapeutics Ltd.
Clarendon House 2 Church Street
HM 11, Hamilton
+441 295 5950
http://www.altamiratherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+15.19% | 12TCr | |
+19.91% | 11TCr | |
-19.80% | 2.04TCr | |
-15.92% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr | |
+119.39% | 1.1TCr |